EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015

Table of contents A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinoma Jella-Andrea Abraham, Olga Golubnitschaja A2 Integrated market access approach amplifying value of “Rx-CDx” Ildar Akhmetov A3 Disaster response: an opportunity to improve global healthcare Russell J. Andrews, Leonidas Quintana A4 USA PPPM: proscriptive, profligate, profiteering medicine-good for 1 % wealthy, not for 99 % unhealthy Russell J. Andrews A5 The role of IDO in a murine model of gingivitis: predictive and therapeutic potentials Babak Baban, Jun Yao Liu, Xu Qin, Tailing Wang, Mahmood S. Mozaffari A6 Specific diets for personalised treatment of diabetes type 2 Viktoriia V. Bati, Tamara V. Meleshko, Olga B. Levchuk, Nadiya V. Boyko A7 Towards personalized physiotherapeutic approach Joanna Bauer, Ewa Boerner, Halina Podbielska A8 Cells, animal, SHIME and in silico models for detection and verification of specific biomarkers of non-communicable chronic diseases Alojz Bomba, Viktor O. Petrov, Volodymyr G. Drobnych, Rostyslav V. Bubnov, Oksana M. Bykova, Nadiya V. Boyko A9 INTERACT-chronic care model: Self-treatment by patients with decision support e-Health solution Hans-Peter Brunner-La Rocca, Lutz Fleischhacker, Olga Golubnitschaja, Frank Heemskerk, Thomas Helms, Tiny Jaarsma, Judita Kinkorova, Jan Ramaekers, Peter Ruff, Ivana Schnur, Emilio Vanoli, Jose Verdu A10 PPPM in cardiovascular medicine in 2015 Hans-Peter Brunner-La Rocca A11 Magnetic resonance imaging of nanoparticles in mice, potential for theranostic and contrast media development – pilot results Rostyslav V. Bubnov, Sergiy A. Grabovetskyi, Olena M. Mykhalchenko, Natalia O. Tymoshok, Oleksandr B. Shcherbakov, Igor P. Semeniv, Mykola Y. Spivak A12 Ultrasound diagnosis for diabetic neuropathy - comparative study Rostyslav V. Bubnov, Tetyana V. Ostapenko A13 Ultrasound for stratification patients with diabetic foot ulcers for prevention and personalized treatment - pilot results Rostyslav V. Bubnov, Nazarii M. Kobyliak, Nadiya M. Zholobak, Mykola Ya. Spivak A14 Project ImaGenX – designing and executing a questionnaire on environment and lifestyle risk of breast cancer John Paul Cauchi A15 Genomics – a new structural brand of predictive, preventive and personalized medicine or the new driver as well? Dmitrii Cherepakhin, Marina Bakay, Artem Borovikov, Sergey Suchkov A16 Survey of questionnaires for evaluation of the quality of life in various medical fields Barbara Cieślik, Agnieszka Migasiewicz, Maria-Luiza Podbielska, Markus Pelleter, Agnieszka Giemza, Halina Podbielska A17 Personalized molecular treatment for muscular dystrophies Sebahattin Cirak A18 Secondary mutations in circulating tumour DNA for acquired drug resistance in patients with advanced ALK + NSCLC Marzia Del Re, Paola Bordi, Valentina Citi, Marta Palombi, Carmine Pinto, Marcello Tiseo, Romano Danesi A19 Recombinant species-specific FcεRI alpha proteins for diagnosis of IgE-mediated allergies in dogs, cats and horses Lukas Einhorn, Judit Fazekas, Martina Muhr, Alexandra Schoos, Lucia Panakova, Ina Herrmann, Krisztina Manzano-Szalai, Kumiko Oida, Edda Fiebiger, Josef Singer, Erika Jensen-Jarolim A20 Global methodology for developmental neurotoxicity testing in humans and animals early and chronically exposed to chemical contaminants Arpiné A. Elnar, Nadia Ouamara, Nadiya Boyko, Xavier Coumoul, Jean-Philippe Antignac, Bruno Le Bizec, Gauthier Eppe, Jenny Renaut, Torsten Bonn, Cédric Guignard, Margherita Ferrante, Maria Liusa Chiusano, Salvatore Cuzzocrea, Gerard O'Keeffe, John Cryan, Michelle Bisson, Amina Barakat, Ihsane Hmamouchi, Nasser Zawia, Anumantha Kanthasamy, Glen E. Kisby, Rui Alves, Oscar Villacañas Pérez, Kim Burgard, Peter Spencer, Norbert Bomba, Martin Haranta, Nina Zaitseva, Irina May, Stéphanie Grojean, Mathilde Body-Malapel, Florencia Harari, Raul Harari, Kristina Yeghiazaryan, Olga Golubnitschaja, Vittorio Calabrese, Christophe Nemos, Rachid Soulimani A21 Mental indicators at young people with attributes hypertension and pre-hypertension Maria E. Evsevyeva, Elena A. Mishenko, Zurida V. Kumukova, Evgeniy V. Chudnovsky, Tatyana A. Smirnova A22 On the approaches to the early diagnosis of stress-induced hypertension in young employees of State law enforcement agencies Maria E. Evsevyeva, Ludmila V. Ivanova, Michail V. Eremin, Maria V. Rostovtseva A23 Сentral aortic pressure and indexes of augmentation in young persons in view of risk factors Maria E. Evsevyeva, Michail V. Eremin, Vladimir I. Koshel, Oksana V. Sergeeva, Nadesgda M. Konovalova A24 Breast cancer prediction and prevention: Are reliable biomarkers in horizon? Shantanu Girotra, Olga Golubnitschaja A25 Flammer Syndrome and potential formation of pre-metastatic niches: A multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease Olga Golubnitschaja, Manuel Debald, Walther Kuhn, Kristina Yeghiazaryan, Rostyslav V. Bubnov, Vadym M. Goncharenko, Ulyana Lushchyk, Godfrey Grech, Katarzyna Konieczka A26 Innovative tools for prenatal diagnostics and monitoring: improving individual pregnancy outcomes and health-economy in EU Olga Golubnitschaja, Jan Jaap Erwich, Vincenzo Costigliola, Kristina Yeghiazaryan, Ulrich Gembruch A27 Immunohistochemical assessment of APUD cells in endometriosis Vadym M. Goncharenko, Vasyl O. Beniuk, Olga V. Kalenska, Rostyslav V. Bubnov A28 Updating personalized management algorithm of endometrial hyperplasia in pre-menopause women Vadym M. Goncharenko, Vasyl O. Beniuk, Rostyslav V. Bubnov, Olga Melnychuk A29 The personified treatment approach of polimorbid patients with periodontal inflammatory diseases Irina A. Gorbacheva, Lyudmila Y. Orekhova, Vadim V. Tachalov A30 Ukrainian experience in hybrid war – the challenge to update algorithms for personalized care and early prevention of different military injuries Olena I. Grechanyk, Rizvan Ya. Abdullaiev, Rostyslav V. Bubnov A31 Tear fluid biomarkers: a comparison of tear fluid sampling and storage protocols Suzanne Hagan, Eilidh Martin, Ian Pearce, Katherine Oliver A32 The correlation of dietary habits with gingival problems during menstruation Cenk Haytac, Fariz Salimov, Servin Yoksul, Anatoly A. Kunin, Natalia S. Moiseeva A33 Genomic medicine in a contemporary Spanish population of prostate cancer: our experience Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara, Antonia Angulo, Francisco Javier Machuca Santa-Cruz A34 Challenges, opportunities and collaborations for personalized medicine applicability in uro-oncological disease Bernardo Herrera-Imbroda, Sergio del Río-González, Maria Fernanda Lara A35 Metabolic hallmarks of cancer as targets for a personalized therapy John Ionescu A36 Influence of genetic polymorphism as a predictor of the development of periodontal disease in patients with gastric ulcer and 12 duodenal ulcer Alfiya Z. Isamulaeva, Anatoly A. Kunin, Shamil Sh. Magomedov, Aida I. Isamulaeva A37 Challenges in diabetic macular edema Tatjana Josifova A38 Overview of the EPMA strategies in laboratory medicine relevant for PPPM Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja, Vincenzo Costigliola A39 EPMA initiative for effective organization of medical travel: European concepts and criteria Vincenzo Costigliola, Marko Kapalla, Juraj Kubáň, Olga Golubnitschaja A40 Design and innovation in e-textiles: implications for PPPM Anthony Kent, Tom Fisher, Tilak Dias A41 Biobank in Pilsen as a member of national node BBMRI_CZ Judita Kinkorová, Ondřej Topolčan A42 Big data in personalized medicine: hype and hope Matthias Kohl A43 The 3P approach as the platform of the European Dentistry Department (DPPPD) Anatoly A. Kunin, Natalia S. Moiseeva A44 The endometrium cytokine patterns for predictive diagnosis of proliferation severity and cancer prevention Andrii I. Kurchenko, Vasyl A. Beniuk, Vadym M. Goncharenko, Rostyslav V. Bubnov, Nadiya V. Boyko, Andriy M. Strokan A45 A monocyte-based in-vitro system for testing individual responses to the implanted material: future for personalized implant construction Julia Kzhyshkowska, Alexandru Gudima, Ksenia S. Stankevich, Victor D. Filimonov4, Harald Klüter, Evgeniya M. Mamontova, Sergei I. Tverdokhlebov A46 Prediction and prevention of adverse health effects by meteorological factors: Biomarker patterns and creation of a device for self-monitoring and integrated care Ulyana B. Lushchyk, Viktor V. Novytskyy, Igor P. Babii, Nadiya G. Lushchyk, Lyudmyla S. Riabets, Ivanna I. Legka A47 Targeting "disease signatures" towards personalized healthcare Mira Marcus-Kalish, Alexis Mitelpunkt, Tal Galili, Neta Shachar, Yoav Benjamini A48 Influence of the skin imperfection on the personal quality of life and possible tools for objective diagnosis Agnieszka Migasiewicz, Markus Pelleter, Joanna Bauer, Ewelina Dereń, Halina Podbielska A49 The new direction in caries prevention based on the ultrastructure of dental hard tissues and filling materials Natalia S. Moiseeva, Anatoly A. Kunin, Dmitry A. Kunin A50 The use of LED radiation in prevention of dental diseases Natalia S. Moiseeva, Yury A. Ippolitov, Dmitry A. Kunin, Alexei N. Morozov, Natalia V. Chirkova, Nakhid T. Aliev A51 Status of endothelial progenitor cells in diabetic nephropathy: predictive and preventive potentials Mahmood S. Mozaffari, Jun Yao Liu, Babak Baban A52 The status of glucocorticoid-induced leucine zipper protein in salivary gland in Sjögren’s syndrome: predictive and personalized treatment potentials Mahmood S. Mozaffari, Jun Yao Liu, Rafik Abdelsayed, Xing-Ming Shi, Babak Baban A53 Maximal aerobic capacity - important quality marker of health Jaroslav Novák, Milan Štork, Václav Zeman A54 The EMPOWER project: laboratory medicine and Horizon 2020 Wytze P. Oosterhuis, Elvar Theodorsson A55 Personality profile manifestations in patient’s attitude to oral care and adherence to doctor’s prescriptions Lyudmila Y. Orekhova, Tatyana V. Kudryavtseva, Elena R. Isaeva, Vadim V. Tachalov, Ekaterina S. Loboda A56 Results of an European survey on personalized medicine addressed to directions of laboratory medicine Mario Pazzagli, Francesca Malentacchi, Irene Mancini, Ivan Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, Ron H.N. van Schaik, Gerard Siest, Elvar Theodorsson, Chiara Di Resta A57 MCI or early dementia predictive speech based diagnosis techniques Matus Pleva, Jozef Juhar A58 Personalized speech based mobile application for eHealth Matus Pleva, Jozef Juhar A59 Circulating tumor cell-free DNA as the biomarker in the management of cancer patients Jiří Polívka jr., Filip Janků, Martin Pešta, Jan Doležal, Milena Králíčková, Jiří Polívka A60 Complex stroke care – educational programme in Stroke Centre University Hospital Plzen Jiří Polívka, Alena Lukešová, Nina Müllerová, Petr Ševčík, Vladimír Rohan A61 Sleep apnea and sleep fragmentation contribute to brain aging Kneginja Richter, Lence Miloseva, Günter Niklewski A62 Personalised approach for sleep disturbances in shift workers Kneginja Richter, Jens Acker, Guenter Niklewski A63 Medical travel and innovative PPPM clusters: new concept of integration Olga Safonicheva, Vincenzo Costigliola A64 Medical travel and women health Olga Safonicheva A65 Continuity of generations in the training of specialists in the field of reconstructive microsurgery Maxim Sautin, Janna Sinelnikova, Sergey Suchkov A66 Telemonitoring of stroke patients – empirical evidence of individual risk management results from an observational study in Germany Songül Secer, Stephan von Bandemer A67 Women’s increasing breast cancer risk with n-6 fatty acid intake explained by estrogen-fatty acid interactive effect on DNA damage: implications for gender-specific nutrition within personalized medicine Niva Shapira A68 Cytobacterioscopy of the gingival crevicular fluid as a method for preventive diagnosis of periodontal diseases Aleksandr Shcherbakov, Anatoly A. Kunin, Natalia S. Moiseeva A69 Use of specially treated composites in dentistry to avoid violations of aesthetics Bogdan R. Shumilovich, Zhanna Lipkind, Yulia Vorobieva, Dmitry A. Kunin, Anastasiia V. Sudareva A70 National eHealth system – platform for preventive, predictive and personalized diabetes care Ivica Smokovski, Tatjana Milenkovic A72 The common energy levels of Prof. Szent-Györgyi, the intrinsic chemistry of melanin, and the muscle physiopathology. Implications in the context of Preventive, Predictive, and Personalized Medicine Arturo Solís-Herrera, María del Carmen Arias-Esparza, Sergey Suchkov A73 Plurality and individuality of hepatocellular carcinoma: PPPM perspectives Krishna Chander Sridhar, Olga Golubnitschaja A74 Strategic aspects of higher medical education reforms to secure newer educational platforms for getting biopharma professionals matures Maria Studneva, Sihong Song, James Creeden, Мark Мandrik, Sergey Suchkov A75 Overview of the strategies and activities of the European Federation of Clinical Chemistry and Laboratory Medicine, (EFLM) Elvar Theodorsson, EFLM A76 New spectroscopic techniques for point of care label free diagnostics Syed A. M. Tofail A77 Tumor markers for personalized medicine and oncology - the role of Laboratory Medicine Ondřej Topolčan, Judita Kinkorová, Ondřej Fiala, Marie Karlíková, Šárka Svobodová, Radek Kučera, Radka Fuchsová, Vladislav Třeška, Václav Šimánek, Ladislav Pecen, Jan Šoupal, Štěpán Svačina2 A78 Modern medical terminology (MMT) as a driver of the global educational reforms Evgeniya Tretyak, Maria Studneva, Sergey Suchkov A79 Juvenile hypertension; the relevance of novel predictive, preventive and personalized assessment of its determinants Francesca M. Trovato, G. Fabio Martines, Daniela Brischetto, Daniela Catalano, Giuseppe Musumeci, Guglielmo M. Trovato A80 Proteomarkers Biotech George Th. Tsangaris, Athanasios K. Anagnostopoulos A81 Proteomics and mass spectrometry based non-invasive prenatal testing of fetal health and pregnancy complications George Th. Tsangaris, Athanasios K. Anagnostopoulos A82 Integrated Ecosystem for an Integrated Care model for Heart Failure (HF) patients including related comorbidities (ZENITH) José Verdú, German Gutiérrez, Jordi Rovira, Marta Martinez, Lutz Fleischhacker, Donna Green, Arthur Garson, Elena Tamburini, Stefano Cuomo, Juan Martinez-Leon, Teresa Abrisqueta, Hans-Peter Brunner-La Rocca, Tiny Jaarsma, Teresa Arredondo, Cecilia Vera, Giuseppe Fico, Olga Golubnitschaja, Fernando Arribas, Martina Onderco, Isabel Vara, on behalf of ZENITH consortium A83 Predictive, preventive and personalized medicine in diabetes onset and complication (MOSAIC project) José Verdú, Francesco Sambo, Barbara Di Camillo, Claudio Cobelli, Andrea Facchinetti, Giuseppe Fico, Riccardo Bellazzi, Lucia Sacchi, Arianna Dagliati, Daniele Segnani, Valentina Tibollo, Manuel Ottaviano, Rafael Gabriel, Leif Groop, Jacqueline Postma, Antonio Martinez, Liisa Hakaste, Tiinamaija Tuomi, Konstantia Zarkogianni, on behalf of MOSAIC consortium A84 Possibilities for personalized therapy of diabetes using in vitro screening of insulin and oral hypoglycemic agents Igor Volchek, Nina Pototskaya, Andrey Petrov A85 The innovative technology for personalized therapy of human diseases based on in vitro drug screening Igor Volchek, Nadezhda Pototskaya, Andrey Petrov A86 Bone destruction and temporomandibular joint: predictive markers, pathogenetic aspects and quality of life Ülle Voog-Oras, Oksana Jagur, Edvitar Leibur, Priit Niibo, Triin Jagomägi, Minh Son Nguyen, Chris Pruunsild, Dagmar Piikov, Mare Saag A87 Sub-optimal health management – global vision for concepts in medical travel Wei Wang A88 Sub-optimal health management: synergic PPPM-TCAM approach Wei Wang A89 Innovative technologies for minimal invasive diagnostics Andreas Weinhäusel, Walter Pulverer, Matthias Wielscher, Manuela Hofner, Christa Noehammer, Regina Soldo, Peter Hettegger, Istvan Gyurjan, Ronald Kulovics, Silvia Schönthaler, Gabriel Beikircher, Albert Kriegner, Stephan Pabinger, Klemens Vierlinger A90 Rare disease diobanks for personalized medicine Ayşe Yüzbaşıoğlu, Meral Özgüç, Member of EuroBioBank - European Network of DNA, Cell and Tissue Banks for Rare Disease

Investigation of Physicochemical Properties of Partially Spent Platinum–Rhenium Reforming Catalyst

Изучены физико-химические свойства частично отработанного катализатора Pt-Re-Cl/ Al2O3 риформинга нефтяных фракций (R-98 UOP). Установлено, что в процессе эксплуатации катализатора происходило изменение текстурных характеристик, химического состава, частичное фазовое превращение алюмооксидного носителя, накопление металлических примесей и углеродистых отложений. Методом ДСК установлено присутствие на поверхности катализатора различных типов углеродистых отложений, выгорающих при различных температурах. Их полное удаление происходит при температурах 500-550 °СThe physicochemical properties of the partially spent catalyst Pt-Re-Cl/Al2O3 reforming of petroleum fractions (R- 98 UOP) have been studied. It has been found that during operation of the catalyst, a reduction of textural characteristics, chemical composition, partial phase transformation of alumina support, and accumulation of metallic impurities and carbon deposits take place. The DSC method has been found the presence on the surface of the catalyst of various types of carbonaceous deposits burnable at different temperatures. Their removal is complete at temperatures 500-550 °

Development Prospects of Oil and Gas Processing Complex in the Krasnoyarsk Region

Рассмотрены сведения о состоянии и перспективах развития нефтяной и газовой промышленности России и Красноярского края. Отмечено стратегическое значение нефтяных и газовых месторождений, находящихся на территории края, в воспроизводстве ресурсов углеводородного сырья и развитии отечественного нефтегазового комплекса. Показана необходимость ускоренного создания современных конкурентоспособных технологий и перерабатывающих отраслей с целью получения высококачественных жидких углеводородных продуктов - моторных топлив, ценного химического сырья и других востребованных продуктов. Это позволит стране и краю занять достойное место среди поставщиков нефти, газа и продуктов их переработки на рынке Азиатско-Тихоокеанского региона.The information on the state and development prospects of oil and gas processing complex in Russia and in the Krasnoyarsk region is considered. A strategical role of the oil and gas fields located in the Krasnoyarsk region in the reproduction of hydrocarbon raw materials and in the development of the native oil and gas complex is emphasized. A topical question for the accelerated creation of modern competitive technologies for oil and gas processing into the valuable liquid hydrocarbon products – motor fuel, chemical raw materials, and other relevant products is substantiated. This will allow our country taking a worthy role in the providing of oil, gas and their processing products in the market of Asia-Pacific region

Development Prospects of Oil and Gas Processing Complex in the Krasnoyarsk Region

Рассмотрены сведения о состоянии и перспективах развития нефтяной и газовой промышленности России и Красноярского края. Отмечено стратегическое значение нефтяных и газовых месторождений, находящихся на территории края, в воспроизводстве ресурсов углеводородного сырья и развитии отечественного нефтегазового комплекса. Показана необходимость ускоренного создания современных конкурентоспособных технологий и перерабатывающих отраслей с целью получения высококачественных жидких углеводородных продуктов - моторных топлив, ценного химического сырья и других востребованных продуктов. Это позволит стране и краю занять достойное место среди поставщиков нефти, газа и продуктов их переработки на рынке Азиатско-Тихоокеанского региона.The information on the state and development prospects of oil and gas processing complex in Russia and in the Krasnoyarsk region is considered. A strategical role of the oil and gas fields located in the Krasnoyarsk region in the reproduction of hydrocarbon raw materials and in the development of the native oil and gas complex is emphasized. A topical question for the accelerated creation of modern competitive technologies for oil and gas processing into the valuable liquid hydrocarbon products – motor fuel, chemical raw materials, and other relevant products is substantiated. This will allow our country taking a worthy role in the providing of oil, gas and their processing products in the market of Asia-Pacific region

Technology and Properties

Нефтяной кокс - основное сырье для производства анодов алюминиевых электролизеров. Качество кокса во многом определяет технологию, экологию и экономику производства алюминия. С точки зрения производителей алюминия, нефтяной кокс должен обладать следующими свойствами: минимальной зольностью и отсутствием каталитических примесей, высокой стойкостью к кислороду и СО2, низкой пористостью и удельным электросопротивлением, механической прочностью, приемлемой для обработки, и хорошей микроструктурой. Нефтяной кокс производят из остатков переработки нефти и вторичных нефтепродуктов. В силу особенностей технологии качество нефтяного кокса является компромиссом между получением светлых нефтепродуктов и сырья для коксования. Поэтому неудивительно, что очень небольшое количество коксов могут удовлетворить всем требованиям алюминиевой промышленности. В статье с точки зрения мирового опыта алюминиевой промышленности рассмотрены вопросы формирования свойств кокса от начала нефтепереработки до склада сырья анодного производства. Предлагаемая статья является первой в серии совместных работ сотрудников Сибирского федерального университета и специалистов Ачинского НПЗ, посвященных строительству и развитию производства нефтяного кокса на Ачинском НПЗ.Petroleum coke is the main raw material for aluminum electrolysis anodes. Quality of coke determinates the technology, ecology and economics of production of aluminum. From the aluminum producers point of view, petroleum coke should have the following characteristics: - a minimum ash content and the absence of impurities, - high resistance to oxygen and CO2, - low porosity and electrical resistivity - mechanical strength, acceptable for processing - good microstructure. Petroleum coke is produced from petroleum residues and secondary petroleum products. Because of the peculiarity of the technology, the quality of petroleum coke is a compromise between the receipt of light fuel and raw coking. It is not surprising that only a very small amount of coke can satisfy all the requirements of the aluminum industry. The purpose this article is formation of cokes properties from the beginning of oil refining up to the anode plant. The article is the first in a lot of cooperated works of the Siberian Federal University and specialists of the Achinsk refinery, dedicated to construction and development of production of petroleum coke at the Achinsk refinery

Technology and Properties

Нефтяной кокс - основное сырье для производства анодов алюминиевых электролизеров. Качество кокса во многом определяет технологию, экологию и экономику производства алюминия. С точки зрения производителей алюминия, нефтяной кокс должен обладать следующими свойствами: минимальной зольностью и отсутствием каталитических примесей, высокой стойкостью к кислороду и СО2, низкой пористостью и удельным электросопротивлением, механической прочностью, приемлемой для обработки, и хорошей микроструктурой. Нефтяной кокс производят из остатков переработки нефти и вторичных нефтепродуктов. В силу особенностей технологии качество нефтяного кокса является компромиссом между получением светлых нефтепродуктов и сырья для коксования. Поэтому неудивительно, что очень небольшое количество коксов могут удовлетворить всем требованиям алюминиевой промышленности. В статье с точки зрения мирового опыта алюминиевой промышленности рассмотрены вопросы формирования свойств кокса от начала нефтепереработки до склада сырья анодного производства. Предлагаемая статья является первой в серии совместных работ сотрудников Сибирского федерального университета и специалистов Ачинского НПЗ, посвященных строительству и развитию производства нефтяного кокса на Ачинском НПЗ.Petroleum coke is the main raw material for aluminum electrolysis anodes. Quality of coke determinates the technology, ecology and economics of production of aluminum. From the aluminum producers point of view, petroleum coke should have the following characteristics: - a minimum ash content and the absence of impurities, - high resistance to oxygen and CO2, - low porosity and electrical resistivity - mechanical strength, acceptable for processing - good microstructure. Petroleum coke is produced from petroleum residues and secondary petroleum products. Because of the peculiarity of the technology, the quality of petroleum coke is a compromise between the receipt of light fuel and raw coking. It is not surprising that only a very small amount of coke can satisfy all the requirements of the aluminum industry. The purpose this article is formation of cokes properties from the beginning of oil refining up to the anode plant. The article is the first in a lot of cooperated works of the Siberian Federal University and specialists of the Achinsk refinery, dedicated to construction and development of production of petroleum coke at the Achinsk refinery

Investigation of Physicochemical Properties of Partially Spent Platinum–Rhenium Reforming Catalyst

Изучены физико-химические свойства частично отработанного катализатора Pt-Re-Cl/ Al2O3 риформинга нефтяных фракций (R-98 UOP). Установлено, что в процессе эксплуатации катализатора происходило изменение текстурных характеристик, химического состава, частичное фазовое превращение алюмооксидного носителя, накопление металлических примесей и углеродистых отложений. Методом ДСК установлено присутствие на поверхности катализатора различных типов углеродистых отложений, выгорающих при различных температурах. Их полное удаление происходит при температурах 500-550 °СThe physicochemical properties of the partially spent catalyst Pt-Re-Cl/Al2O3 reforming of petroleum fractions (R- 98 UOP) have been studied. It has been found that during operation of the catalyst, a reduction of textural characteristics, chemical composition, partial phase transformation of alumina support, and accumulation of metallic impurities and carbon deposits take place. The DSC method has been found the presence on the surface of the catalyst of various types of carbonaceous deposits burnable at different temperatures. Their removal is complete at temperatures 500-550 °

Novel Zirconia Based Catalysts for the Isomerization of Alkanes of Petroleum Fractions

В статье представлены результаты исследований закономерностей формирования фазового состава и текстурных свойств катализаторов на основе диоксида циркония, модифицированного сульфатными и вольфраматными анионами и различными трехвалентными катионами в зависимости от состава предшественников катализаторов и условий приготовления. Изучены каталитические свойства в реакциях изомеризации н-алканов С4-С7. Показано, что сульфатированные катализаторы эффективны при изомеризации низкомолекулярных алканов от бутана до гексана. Для изомеризации алканов гексан- гептановых фракций наиболее эффективны вольфраматсодержащие катализаторы.The data on the study of the formation of phase composition and textural properties of the catalysts based on zirconia promoted by sulphate and tungstate anions and metal cations depended on the composition of catalyst precursors and preparation conditions are presented in the paper. Catalytic activity for the reaction of skeletal isomerization of C4-C7 n-alkanes are evaluated. Sulphated zirconia catalysts are shown to behave high catalytic activity for isomerization of C4-C6 n-alkanes. However, the tungstated zirconia based catalysts were mostly effective for selective isomerization of C6-C7 n-alkanes into branched isomers with high octane numbers

Novel Zirconia Based Catalysts for the Isomerization of Alkanes of Petroleum Fractions

В статье представлены результаты исследований закономерностей формирования фазового состава и текстурных свойств катализаторов на основе диоксида циркония, модифицированного сульфатными и вольфраматными анионами и различными трехвалентными катионами в зависимости от состава предшественников катализаторов и условий приготовления. Изучены каталитические свойства в реакциях изомеризации н-алканов С4-С7. Показано, что сульфатированные катализаторы эффективны при изомеризации низкомолекулярных алканов от бутана до гексана. Для изомеризации алканов гексан- гептановых фракций наиболее эффективны вольфраматсодержащие катализаторы.The data on the study of the formation of phase composition and textural properties of the catalysts based on zirconia promoted by sulphate and tungstate anions and metal cations depended on the composition of catalyst precursors and preparation conditions are presented in the paper. Catalytic activity for the reaction of skeletal isomerization of C4-C7 n-alkanes are evaluated. Sulphated zirconia catalysts are shown to behave high catalytic activity for isomerization of C4-C6 n-alkanes. However, the tungstated zirconia based catalysts were mostly effective for selective isomerization of C6-C7 n-alkanes into branched isomers with high octane numbers

Modeling of Technological Schemes for Production of Motor Spirits

Определены возможные и наиболее целесообразные направления развития технологической схемы нефтеперерабатывающего предприятия, обеспечивающие выпуск моторных топлив в соответствии с мировыми экологическими и эксплуатационными требованиями. Выход светлых нефтепродуктов при реализации схемы №1 в целом по заводу составит 86,8 %, а для схемы №2 - 87,2 % при глубине переработки нефти ~96 %.Possible and most expedient directions of technological scheme of the oil refining factory providing output of motor fuels in conformity with world environmental and operational requirements.are determined. The yield of refined oils at implementation of the schema №1 as a whole on plant will compound 86,8 %, and for the schema №2 - 87,2 % at depth of petroleum refining of ~96 %